ConawayD.C. (1995). Using NSAIDs safely in the elderly. Hospital Medicine, 31, 23–34.
2.
DeWittD.L.MeadeE.A., & SmithW.L. (1993). PGH synthase isoenzyme selectivity: The potential for safer nonsteroidal anti-inflammatory drugs. The American Journal of Medicine, 95 (2A), 40S–44S.
3.
HerfindalE.T.GourleyD.R., & HartL.L., Eds. (1992). Clinical pharmacy and therapeutics, 5th ed.Baltimore: Williams & Wilkins.
4.
HirschowitzB.I. (1997). NSAIDs and the gut: Understanding and preventing problems. The Journal of Musculoskeletal Medicine, 14, 38–46.
5.
Health Management Bulletin: Clinical Issues in Drug Management. (1997, July). American Medical Association, 1–8.
6.
JohnsonA.G.NguyenT.V., & DayR.O. (1994). Do nonsteroidal antiinflammatory drugs affect blood pressure?Annals of Internal Medicine, 121, 289–300.
7.
SinghG.RameyD.MorfeldD.ShiH., & FriesJ. (1995). Epidemiology of NSAID-induced gastrointestinal side effects. Arthritis and Rheumatism, 38 (suppl), 206.
8.
SkeithK.J.RussellA.S.JamaliF.CoatesJ., & FriedmanH. (1990). Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis. The Journal of Rheumatology, 17, 1008–1010.
9.
StewartC.F.FlemingR.A.ArkinC.R., & EvansW.E. (1990). Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis. Clinical Pharmacology Therapeutics, 47, 540–546.
10.
StewartW.F.KawasC.CorradaM.MetterJ. (1997). Risk of Alzheimer's disease and duration of NSAID use. Neurology, 48, 626–632.